Global Companion Diagnostics Market Research Report 2023

Companion Diagnostics Market

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient’s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Companion Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Companion Diagnostics Market Report

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Companion Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Polymerase Chain Reaction (PCR)

1.2.3 Immunohistochemistry (IHC)

1.2.4 In Situ Hybridization (ISH)

1.2.5 Next Generation Sequencing (NGS)

1.3 Market by Application

1.3.1 Global Companion Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Pharmaceutical Companies

1.3.4 Laboratories

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Companion Diagnostics Market Perspective (2018-2029)

2.2 Companion Diagnostics Growth Trends by Region

2.2.1 Global Companion Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Companion Diagnostics Historic Market Size by Region (2018-2023)

2.2.3 Companion Diagnostics Forecasted Market Size by Region (2024-2029)

2.3 Companion Diagnostics Market Dynamics

2.3.1 Companion Diagnostics Industry Trends

2.3.2 Companion Diagnostics Market Drivers

2.3.3 Companion Diagnostics Market Challenges

2.3.4 Companion Diagnostics Market Restraints

3.1 Global Top Companion Diagnostics Players by Revenue

3.1.1 Global Top Companion Diagnostics Players by Revenue (2018-2023)

3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2018-2023)

3.2 Global Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Companion Diagnostics Revenue

3.4 Global Companion Diagnostics Market Concentration Ratio

3.4.1 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics Revenue in 2022

3.5 Companion Diagnostics Key Players Head office and Area Served

3.6 Key Players Companion Diagnostics Product Solution and Service

3.7 Date of Enter into Companion Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Companion Diagnostics Historic Market Size by Type (2018-2023)

4.2 Global Companion Diagnostics Forecasted Market Size by Type (2024-2029)

5.1 Global Companion Diagnostics Historic Market Size by Application (2018-2023)

5.2 Global Companion Diagnostics Forecasted Market Size by Application (2024-2029)

6.1 North America Companion Diagnostics Market Size (2018-2029)

6.2 North America Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Companion Diagnostics Market Size by Country (2018-2023)

6.4 North America Companion Diagnostics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Companion Diagnostics Market Size (2018-2029)

7.2 Europe Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Companion Diagnostics Market Size by Country (2018-2023)

7.4 Europe Companion Diagnostics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Companion Diagnostics Market Size (2018-2029)

8.2 Asia-Pacific Companion Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Companion Diagnostics Market Size by Region (2018-2023)

8.4 Asia-Pacific Companion Diagnostics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Companion Diagnostics Market Size (2018-2029)

9.2 Latin America Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Companion Diagnostics Market Size by Country (2018-2023)

9.4 Latin America Companion Diagnostics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Companion Diagnostics Market Size (2018-2029)

10.2 Middle East & Africa Companion Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Companion Diagnostics Market Size by Country (2018-2023)

10.4 Middle East & Africa Companion Diagnostics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche Holdings

11.1.1 Roche Holdings Company Detail

11.1.2 Roche Holdings Business Overview

11.1.3 Roche Holdings Companion Diagnostics Introduction

11.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2018-2023)

11.1.5 Roche Holdings Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Detail

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Companion Diagnostics Introduction

11.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2018-2023)

11.2.5 Abbott Laboratories Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Detail

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Companion Diagnostics Introduction

11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2018-2023)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Detail

11.4.2 Agilent Technologies Business Overview

11.4.3 Agilent Technologies Companion Diagnostics Introduction

11.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2018-2023)

11.4.5 Agilent Technologies Recent Development

11.5 Life Technologies

11.5.1 Life Technologies Company Detail

11.5.2 Life Technologies Business Overview

11.5.3 Life Technologies Companion Diagnostics Introduction

11.5.4 Life Technologies Revenue in Companion Diagnostics Business (2018-2023)

11.5.5 Life Technologies Recent Development

11.6 GE Healthcare

11.6.1 GE Healthcare Company Detail

11.6.2 GE Healthcare Business Overview

11.6.3 GE Healthcare Companion Diagnostics Introduction

11.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2018-2023)

11.6.5 GE Healthcare Recent Development

11.7 Agendia

11.7.1 Agendia Company Detail

11.7.2 Agendia Business Overview

11.7.3 Agendia Companion Diagnostics Introduction

11.7.4 Agendia Revenue in Companion Diagnostics Business (2018-2023)

11.7.5 Agendia Recent Development

11.8 Qiagen

11.8.1 Qiagen Company Detail

11.8.2 Qiagen Business Overview

11.8.3 Qiagen Companion Diagnostics Introduction

11.8.4 Qiagen Revenue in Companion Diagnostics Business (2018-2023)

11.8.5 Qiagen Recent Development

11.9 Genomic Health

11.9.1 Genomic Health Company Detail

11.9.2 Genomic Health Business Overview

11.9.3 Genomic Health Companion Diagnostics Introduction

11.9.4 Genomic Health Revenue in Companion Diagnostics Business (2018-2023)

11.9.5 Genomic Health Recent Development

11.10 Myriad Genetics

11.10.1 Myriad Genetics Company Detail

11.10.2 Myriad Genetics Business Overview

11.10.3 Myriad Genetics Companion Diagnostics Introduction

11.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2018-2023)

11.10.5 Myriad Genetics Recent Development

11.11 Advanced Cell Diagnostics

11.11.1 Advanced Cell Diagnostics Company Detail

11.11.2 Advanced Cell Diagnostics Business Overview

11.11.3 Advanced Cell Diagnostics Companion Diagnostics Introduction

11.11.4 Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2018-2023)

11.11.5 Advanced Cell Diagnostics Recent Development

11.12 Danaher

11.12.1 Danaher Company Detail

11.12.2 Danaher Business Overview

11.12.3 Danaher Companion Diagnostics Introduction

11.12.4 Danaher Revenue in Companion Diagnostics Business (2018-2023)

11.12.5 Danaher Recent Development

11.13 Applied Proteomics

11.13.1 Applied Proteomics Company Detail

11.13.2 Applied Proteomics Business Overview

11.13.3 Applied Proteomics Companion Diagnostics Introduction

11.13.4 Applied Proteomics Revenue in Companion Diagnostics Business (2018-2023)

11.13.5 Applied Proteomics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Polymerase Chain Reaction (PCR)

    Table 3. Key Players of Immunohistochemistry (IHC)

    Table 4. Key Players of In Situ Hybridization (ISH)

    Table 5. Key Players of Next Generation Sequencing (NGS)

    Table 6. Global Companion Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Companion Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Companion Diagnostics Market Share by Region (2018-2023)

    Table 10. Global Companion Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Companion Diagnostics Market Share by Region (2024-2029)

    Table 12. Companion Diagnostics Market Trends

    Table 13. Companion Diagnostics Market Drivers

    Table 14. Companion Diagnostics Market Challenges

    Table 15. Companion Diagnostics Market Restraints

    Table 16. Global Companion Diagnostics Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Companion Diagnostics Market Share by Players (2018-2023)

    Table 18. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)

    Table 19. Ranking of Global Top Companion Diagnostics Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Companion Diagnostics Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Companion Diagnostics Product Solution and Service

    Table 23. Date of Enter into Companion Diagnostics Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Companion Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Companion Diagnostics Revenue Market Share by Type (2018-2023)

    Table 27. Global Companion Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Companion Diagnostics Revenue Market Share by Type (2024-2029)

    Table 29. Global Companion Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Companion Diagnostics Revenue Market Share by Application (2018-2023)

    Table 31. Global Companion Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Companion Diagnostics Revenue Market Share by Application (2024-2029)

    Table 33. North America Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Companion Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Companion Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Companion Diagnostics Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Companion Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Companion Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Roche Holdings Company Detail

    Table 49. Roche Holdings Business Overview

    Table 50. Roche Holdings Companion Diagnostics Product

    Table 51. Roche Holdings Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 52. Roche Holdings Recent Development

    Table 53. Abbott Laboratories Company Detail

    Table 54. Abbott Laboratories Business Overview

    Table 55. Abbott Laboratories Companion Diagnostics Product

    Table 56. Abbott Laboratories Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 57. Abbott Laboratories Recent Development

    Table 58. Thermo Fisher Scientific Company Detail

    Table 59. Thermo Fisher Scientific Business Overview

    Table 60. Thermo Fisher Scientific Companion Diagnostics Product

    Table 61. Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 62. Thermo Fisher Scientific Recent Development

    Table 63. Agilent Technologies Company Detail

    Table 64. Agilent Technologies Business Overview

    Table 65. Agilent Technologies Companion Diagnostics Product

    Table 66. Agilent Technologies Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 67. Agilent Technologies Recent Development

    Table 68. Life Technologies Company Detail

    Table 69. Life Technologies Business Overview

    Table 70. Life Technologies Companion Diagnostics Product

    Table 71. Life Technologies Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 72. Life Technologies Recent Development

    Table 73. GE Healthcare Company Detail

    Table 74. GE Healthcare Business Overview

    Table 75. GE Healthcare Companion Diagnostics Product

    Table 76. GE Healthcare Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 77. GE Healthcare Recent Development

    Table 78. Agendia Company Detail

    Table 79. Agendia Business Overview

    Table 80. Agendia Companion Diagnostics Product

    Table 81. Agendia Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 82. Agendia Recent Development

    Table 83. Qiagen Company Detail

    Table 84. Qiagen Business Overview

    Table 85. Qiagen Companion Diagnostics Product

    Table 86. Qiagen Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 87. Qiagen Recent Development

    Table 88. Genomic Health Company Detail

    Table 89. Genomic Health Business Overview

    Table 90. Genomic Health Companion Diagnostics Product

    Table 91. Genomic Health Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 92. Genomic Health Recent Development

    Table 93. Myriad Genetics Company Detail

    Table 94. Myriad Genetics Business Overview

    Table 95. Myriad Genetics Companion Diagnostics Product

    Table 96. Myriad Genetics Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 97. Myriad Genetics Recent Development

    Table 98. Advanced Cell Diagnostics Company Detail

    Table 99. Advanced Cell Diagnostics Business Overview

    Table 100. Advanced Cell Diagnostics Companion Diagnostics Product

    Table 101. Advanced Cell Diagnostics Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 102. Advanced Cell Diagnostics Recent Development

    Table 103. Danaher Company Detail

    Table 104. Danaher Business Overview

    Table 105. Danaher Companion Diagnostics Product

    Table 106. Danaher Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 107. Danaher Recent Development

    Table 108. Applied Proteomics Company Detail

    Table 109. Applied Proteomics Business Overview

    Table 110. Applied Proteomics Companion Diagnostics Product

    Table 111. Applied Proteomics Revenue in Companion Diagnostics Business (2018-2023) & (US$ Million)

    Table 112. Applied Proteomics Recent Development

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Companion Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Companion Diagnostics Market Share by Type: 2022 VS 2029

    Figure 3. Polymerase Chain Reaction (PCR) Features

    Figure 4. Immunohistochemistry (IHC) Features

    Figure 5. In Situ Hybridization (ISH) Features

    Figure 6. Next Generation Sequencing (NGS) Features

    Figure 7. Global Companion Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Companion Diagnostics Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals Case Studies

    Figure 10. Pharmaceutical Companies Case Studies

    Figure 11. Laboratories Case Studies

    Figure 12. Other Case Studies

    Figure 13. Companion Diagnostics Report Years Considered

    Figure 14. Global Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Companion Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Companion Diagnostics Market Share by Region: 2022 VS 2029

    Figure 17. Global Companion Diagnostics Market Share by Players in 2022

    Figure 18. Global Top Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Companion Diagnostics Revenue in 2022

    Figure 20. North America Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Companion Diagnostics Market Share by Country (2018-2029)

    Figure 22. United States Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Companion Diagnostics Market Share by Country (2018-2029)

    Figure 26. Germany Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Companion Diagnostics Market Share by Region (2018-2029)

    Figure 34. China Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Companion Diagnostics Market Share by Country (2018-2029)

    Figure 42. Mexico Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Companion Diagnostics Market Share by Country (2018-2029)

    Figure 46. Turkey Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Companion Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Roche Holdings Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 49. Abbott Laboratories Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 51. Agilent Technologies Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 52. Life Technologies Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 53. GE Healthcare Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 54. Agendia Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 55. Qiagen Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 56. Genomic Health Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 57. Myriad Genetics Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 58. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 59. Danaher Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 60. Applied Proteomics Revenue Growth Rate in Companion Diagnostics Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed